1. Home
  2. ZENA vs IVA Comparison

ZENA vs IVA Comparison

Compare ZENA & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZENA
  • IVA
  • Stock Information
  • Founded
  • ZENA 2017
  • IVA 2011
  • Country
  • ZENA Canada
  • IVA France
  • Employees
  • ZENA N/A
  • IVA N/A
  • Industry
  • ZENA
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZENA
  • IVA Health Care
  • Exchange
  • ZENA NYSE
  • IVA Nasdaq
  • Market Cap
  • ZENA 128.8M
  • IVA 117.3M
  • IPO Year
  • ZENA N/A
  • IVA 2020
  • Fundamental
  • Price
  • ZENA $6.12
  • IVA $2.16
  • Analyst Decision
  • ZENA
  • IVA Strong Buy
  • Analyst Count
  • ZENA 0
  • IVA 4
  • Target Price
  • ZENA N/A
  • IVA $13.25
  • AVG Volume (30 Days)
  • ZENA 1.5M
  • IVA 7.3K
  • Earning Date
  • ZENA 01-01-0001
  • IVA 09-25-2024
  • Dividend Yield
  • ZENA N/A
  • IVA N/A
  • EPS Growth
  • ZENA N/A
  • IVA N/A
  • EPS
  • ZENA N/A
  • IVA N/A
  • Revenue
  • ZENA $1,476,462.00
  • IVA $20,652,523.00
  • Revenue This Year
  • ZENA N/A
  • IVA N/A
  • Revenue Next Year
  • ZENA N/A
  • IVA $361.78
  • P/E Ratio
  • ZENA N/A
  • IVA N/A
  • Revenue Growth
  • ZENA 9.19
  • IVA N/A
  • 52 Week Low
  • ZENA $1.41
  • IVA $1.53
  • 52 Week High
  • ZENA $12.43
  • IVA $4.50
  • Technical
  • Relative Strength Index (RSI)
  • ZENA N/A
  • IVA 38.30
  • Support Level
  • ZENA N/A
  • IVA $2.11
  • Resistance Level
  • ZENA N/A
  • IVA $2.24
  • Average True Range (ATR)
  • ZENA 0.00
  • IVA 0.07
  • MACD
  • ZENA 0.00
  • IVA 0.01
  • Stochastic Oscillator
  • ZENA 0.00
  • IVA 22.07

About ZENA ZENATECH INC

ZenaTech Inc is a enterprise software technology company that specializes in mission-critical cloud-based applications integrated with smart hardware to deliver innovative solutions across diverse industries. The Company operates in software development technology, sales, and distribution. The Company is also developing a drone manufacturing, sales, and distribution business. The company operates in two segments which is software development technology, sales, and distribution, as well as drone manufacturing, sales, and distribution.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: